AOAC Final Action Methods in 2017

P ACQUETTE & T HOMPSON : J OURNAL OF AOAC I NTERNATIONAL V OL . 101, N O . 2, 2018 557

Table 6. ( continued )

RSD r (AES versus MS)

RSD R (AES versus MS)

mg/100 g a

SMPR: <10%

MS versus AES SMPR: <5%

ICP-MS mean

ICP-AES mean

ICP-MS RSD r

ICP-MS RSD R

ICP-AES RSD r

ICP-AES RSD R

Sample

Difference, %

Difference

Difference

b

b

b

Whole-Milk Liquid

0.00228 0.002 0.00218 0.002

13

3.6 2.0

6.4 5.2 10 b 5.2 63 b 4.8 4.5 4.2 5.0 3.8 4.7 3.7 6.6 3.2 3.4 2.9 3.6 2.6 2.4 3.8 3.3 2.7 3.6 4.8 1.8 4.6 3.2 18 b 6.5 5.2 7.8 4.5 6.3 6.9 4.6 5.0 2.8 5.0 4.2 2.9 4.4 3.2 5.0 2.7 4.4 3.7 4.5 11 b

43 b 50 b

Whole-Milk Powder

8.6

3.3 38 b

1.3

38 40

0.00664 c

7.3 b 4.3 45 b

Whey Powder

0.009

– 30 – 11 – 19

30.7

b

b

b

Whey Protein Concentrate

0.00803 0.009

0.000828 c

b

b

b

Butter

0.001 0.013

11.5 b

39 b

Cheese

0.0143

10

3.1 2.5

8.4 1.8

34.2 11.3

Downloaded from https://academic.oup.com/jaoac/article-abstract/101/2/536/5653941 by guest on 05 May 2020

Mean (above SMPR limit)

2.0

4.1

15.7

Sodium

Adult Low-Fat Powder

24.8 138 139 102 103 18.7 20.7 27.4 27.1 17.4 27.2 16.2 15.8 25.7 18.1 12.1 29.3 37.5 33.6 868 265 243 1014 29.8 90.2 70.2 95.3 40.8 23.9 44.2 22.8 51.8 47.9 26.3 41.4 23.7 33.5 49.8 29.6 4.87 b

24.5 140 138 102 102 4.96 18.5 20.3 26.9 26.9 17.5 26.6 15.9 15.5 25.2 18.4 12.2 29.3 36.7 33.5 933 261 243 972 29.7 89.5 70.8 94.9 41.1 23.8 44.4 22.6 51.8 48.3 25.6 41.3 23.6 32.3 49.6 29.1

1.1

1.3 2.3 3.3 1.0 1.5 1.7 0.8 1.8 1.7 1.3 0.7 1.4 1.3 2.2 1.1 1.3 1.8 0.6 0.9 1.8 1.3 1.3 3.2 1.8 1.5 2.0 3.2 3.2 3.6 3.2 1.7 0.9 2.1 1.4 1.6 1.7 2.0 1.4 1.3 2.2 1.3

1.8 2.2 3.1 1.7 0.9 4.8 3.4 3.6 4.5 1.8 1.5 3.1 2.4 2.6 4.2 3.6 2.9 1.4 2.5 1.7 4.5 2.1 3.2 1.5 2.6 1.7 2.6 2.0 3.5 1.8 2.3 3.9 3.0 3.0 2.0 1.2 1.4 1.2 3.7 4.7 2.2

0.5

8.1 4.8 5.9 6.1 5.5 6.8 8.7 8.2 8.0 8.0 7.5 7.8 9.1 8.1 9.3 6.6 7.7 5.4 7.2 5.7 5.0 5.8 8.6 7.1 7.1 8.3 2.5 6.2 4.1 7.8 8.3 8.3 7.0 7.1 7.8 7.0 8.7 8.1 7.4 6.7

4.0

Adult High-Fat RTF

– 1.2

– 0.1 – 0.2

– 0.2

Placebo, High-Fat Adult High-Protein Placebo, High-Protein

0.7

2.2 1.4 1.8 6.8 3.6 5.3 5.4 4.4 5.3 5.1 4.0 5.8 5.4 5.8 1.8 5.8 0.8 4.0

– 0.3

0.8

0.6

– 0.6

Placebo, Child Milk

– 1.7

3.1 2.7 1.8 2.8 0.6 0.8 1.7 1.1 0.4 3.1 2.3 1.2 0.8 1.6 3.2 0.8 0.0

13.4

Child Milk Powder

1.0 1.9 2.0 0.7 2.3 1.9 1.7 2.1 0.1 2.2 0.3 1.5 0.0 4.2 0.6

Child Elemental Powder Infant Elemental Powder

Placebo, Elemental

Infant, Partly Hydrolyzed Milk Infant, Partly Hydrolyzed Soy

– 0.6

Infant FOS/GOS Powder

Infant Powder Milk Infant Powder Soy Infant RTF Control Placebo, Infant RTF

– 1.4 – 0.5

Toddler Powder

Whole-Milk Liquid

Whole-Milk Powder

– 0.1

Whey Powder

– 7.2

– 12

Whey Protein Concentrate

– 1.5

Butter

0.6 0.8 2.6

Cheese

– 0.3

Mean (above SMPR limit)

1.1

Phosphorus

Adult Low-Fat Powder

0.2 0.8

– 0.3 – 0.6 – 1.1 – 0.2 – 1.4

2.6

Adult High-Fat RTF

– 2.5 – 3.8 – 0.8 – 0.5

Placebo, High-Fat Adult High-Protein Placebo, High-Protein

– 0.8

0.5

– 0.8

Placebo, Child Milk

0.4

0.6 3.0 1.0 1.6 0.4

2.9 5.5 3.3 2.9 4.1 3.4 3.8 3.6 5.4 3.0 3.0

Child Milk Powder

– 0.6

Child Elemental Powder Infant Elemental Powder

1.0 0.1

Placebo, Elemental

– 0.8

Infant, Partly Hydrolyzed Milk Infant, Partly Hydrolyzed Soy

2.7 0.2 0.6 3.5 0.5 1.7

– 0.5 – 0.7 – 0.2

Infant FOS/GOS Powder

Infant Powder Milk Infant Powder Soy Infant RTF Control

2.4 2.5 0.9